News

Published on 19 Sep 2024 on Insider Monkey · via Yahoo Finance

Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy...


Article preview image

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Vera Therapeutics, Inc. (NASDAQ:VERA) stands against the other mid-cap healthcare stocks.

Global Healthcare Market: Growth Projections, Challenges, and Tech-Driven Innovations

According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023. Through 2027, it is projected to grow at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion. Hospitals, digital health, and healthcare services are some of the segments that make up the global healthcare market. Between 2024 and 2029, the hospital market alone is expected to increase by 4.18% annually, reaching a market value of $5.19 trillion.

NASDAQ.VERA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney...

On Saturday, Vera Therapeutics Inc. (NASDAQ:VERA) released data from its ORIGIN Phase 2b trial of...

Benzinga · via Yahoo Finance 28 Oct 2024

Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024?

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, ...

Insider Monkey · via Yahoo Finance 29 Sep 2024

Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy...

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 19 Sep 2024

Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock...

Key Insights Significantly high institutional ownership implies Vera Therapeutics' stock price is...

Simply Wall St. via Yahoo Finance 6 May 2024

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing...

GuruFocus.com via Yahoo Finance 12 Apr 2024

Vera Therapeutics executive sells over $228k in company stock

In a recent transaction, Joseph R. Young, the Senior Vice President of Finance and Chief Accounti...

Investing.com 11 Apr 2024

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact -...

On Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences I...

Benzinga 11 Apr 2024

Vertex Pharma’s takeover of Alpine Immune is a strategic fit: analysts

Alpine Immune’s lead candidate is being evaluated as a potential treatment for IgA Nephropathy, o...

Market Watch 11 Apr 2024

Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer

(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total ...

Bloomberg via Yahoo Finance 11 Apr 2024

Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vera Therapeutics fair value estimate is...

Simply Wall St. via Yahoo Finance 11 Feb 2024